Source link : https://newshealth.biz/health-news/immunotherapy-duo-shows-sustained-benefit-in-liver-cancer/
Long-term survival data further support nivolumab plus ipilimumab as first-line standard of care for patients with inoperable liver cancer. Medscape Medical News Source link : https://www.medscape.com/viewarticle/immunotherapy-duo-shows-sustained-benefit-liver-cancer-2026a100024r?src=rss Author : Publish date : 2026-01-22 10:57:00 Copyright for syndicated content belongs to the linked Source.
The post Immunotherapy Duo Shows Sustained Benefit in Liver Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-01-22 10:57:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8